The Zacks Analyst Blog Roche Holding, Comcast, Eaton Corp and National Presto Industries

For Immediate ReleasesChicago, IL – March 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Roche Holding AG RHHBY, Comcast Corp. CMCSA, Eaton Corp. plc ETN and National Presto Industries, Inc. NPK.Here are highlights from Tuesday’s Analyst Blog:Top Analyst Reports for Roche, Comcast and EatonThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG, Comcast Corp. and Eaton Corp. plc, as well as a micro-cap stock National Presto Industries, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>> Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Pre-Markets Up on "Narrower" April 2nd Tariffs Today's Featured Research ReportsRoche’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+39.7% vs. -2.9%). The company’s top-line growth is being driven by high demand for its drugs and diagnostic tests. Growth in demand for Vabysmo, Phesgo, Ocrevus and Hemlibra boosted the top line. Vabysmo has put up a stellar performance against Eylea.Roche is also looking to diversify its portfolio in the wake of declining sales from legacy drugs (Avastin, Herceptin, MabThera and Actemra) due to competition from biosimilars. Roche has also made strategic acquisitions to expand its portfolio/pipeline. The recent collaboration with Zealand Pharma for its obesity candidate will expand its pipeline in the field of cardiovascular, renal and metabolic diseases.Higher demand for immunodiagnostic, pathology and molecular boosts the diagnostics business. However, recent pipeline setbacks are concerning. Roche has also made a late entry into the lucrative obesity space.(You can read the full research report on Roche here >>>)Shares of Comcast have underperformed the Zacks Cable Television industry over the past year (-11.1% vs. -2.9%). The company persistently suffers from video-subscriber attrition due to cord-cutting. Broadband prospects are suffering from increased competition from fixed wireless and fiber businesses. Additionally, a leveraged balance sheet is a major concern.Nevertheless, Comcast is benefiting from steady growth in domestic wireless subscribers. The company’s plan to transition to DOCSIS 4.0 holds promise. The technology will expand it much faster and at a lower cost compared with its competitors. Decreasing marketing and promotional expenses bode well for CMCSA's profitability.Comcast’s streaming service, Peacock, is a key catalyst in driving broadband sales. Recovery in the theme park and movie business bodes well for bottom line growth. Strong free cash flow generation ability is noteworthy.(You can read the full research report on Comcast here >>>)Eaton’s shares have declined -9.5% over the past six months against the Zacks Manufacturing - Electronics industry’s decline of -11.6%. The company’s Eaton’s global operations expose it to unpredictable currency translation, cyber security threats, changes in tax rates and security breaches, which might impact operations. The shortage of raw materials and supplier insolvencies might impact production and operations.Nevertheless, Eaton's consistent research and development work allows the company to develop new products and cater to a wider customer base. Eaton is aided by rising demand from the new AI-data center and contributions from its organic assets.Eaton has been expanding its footprints via acquisitions and organic initiatives. Reindustrialization and megatrends will create more opportunities for Eaton. Our model expects total revenues to improve year over year in the 2025-2027 period.(You can read the full research report on Eaton here >>>)Shares of National Presto have outperformed the Zacks Diversified Operations industry over the past year (+12.3% vs. +3.7%). This microcap company with market capitalization of $638.48 million offers strong long-term visibility driven by a $1.1 billion defense backlog, nearly double 2023 levels, with multi-year contracts extending through 2028. Growth is supported by U.S. defense spending, with the company aligned to priority programs such as 40mm ammunition and Ukraine resupply.In 2024, net earnings rose 20% to $41.5 million, driven by Defense segment growth and margin expansion in Housewares. Strategic investments, including a new 507,000 sq. ft. facility, enhance logistics capacity. Stable dividends reflect strong cash generation and conservative capital allocation.However, challenges include heavy reliance on U.S. defense contracts, exposure to tariff volatility in Asian-sourced segments, and a cybersecurity incident with undetermined financial impact. The Safety segment remains unprofitable, and Housewares faces margin pressure from industry consolidation.(You can read the full research report on National Presto here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Previewreports. If you want an email notification each time Sheraz publishes a new article, please click here>>>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com                                     https://www.zacks.com                                                Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance  for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY): Free Stock Analysis Report Comcast Corporation (CMCSA): Free Stock Analysis Report Eaton Corporation, PLC (ETN): Free Stock Analysis Report National Presto Industries, Inc. (NPK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks